Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

SS Pharm./Torii developing new antiallergic agent

March 13, 1997

Novel LT biosynthesis inhibitor discovered by Abbott

March 11, 1997

Fluticasone + loratadine for seasonal allergic rhinitis

March 10, 1997

Spiros products progressing through pipeline

March 10, 1997

New PDE III/IV inhibitor described

March 10, 1997

HLE inhibitors from P&U

March 5, 1997

Antiallergic compounds disclosed by Meiji Seika

Feb. 28, 1997

PathoGenesis to seek approval for tobramycin

Feb. 27, 1997

Positive clinical results for inhaled indomethacin

Feb. 27, 1997

Mediator release inhibitors described by French investigators

Feb. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...